Efficient Sensing of a 4-Segmented Rift Valley Fever Virus Vaccine Candidate by Human Monocytes

Area of Science:

• Immunology
• Vaccinology
• Virology

Background:

• Rift Valley Fever (RVF) is a mosquito-borne viral disease with significant public health and economic impact.
• Live-attenuated vaccines are a promising strategy for RVF prevention.
• The RVFV-4s vaccine has shown safety and efficacy in preclinical and early clinical studies.

Purpose of the Study:

• To investigate the impact of the live-attenuated RVFV-4s vaccine on innate immune responses.
• To understand the mechanisms by which RVFV-4s influences immune cell activation.

Main Methods:

• Primary human monocytes were stimulated with RVFV-4s.
• Expression of costimulatory molecules and proinflammatory cytokines was analyzed.

Main Results:

• RVFV-4s significantly enhances the expression of costimulatory molecules on monocytes, crucial for T cell activation.
• The vaccine also induces a proinflammatory cytokine response in primary human monocytes.

Conclusions:

• The RVFV-4s vaccine modulates innate immune responses by enhancing costimulatory molecule expression and inducing proinflammatory cytokines.
• These findings provide insights into the immunomodulatory effects of RVFV-4s, supporting its potential as an effective vaccine against Rift Valley Fever.